A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system

Bispecific T-cell engagers (BiTEs) may break multiple barriers that currently limit the use of immunotherapy in glioblastoma patients. We have recently described a novel BiTE specific for a mutated form of the epidermal growth factor receptor, EGFRvIII, that exerts potent antineoplastic effects agai...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Choi, Bryan D., Pastan, Ira, Bigner, Darell D., Sampson, John H.
Médium: Artigo
Jazyk:Inglês
Vydáno: Landes Bioscience 2013
Témata:
Author's View
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3654588/
https://ncbi.nlm.nih.gov/pubmed/23734318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.23639
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky